Should Surgeons Target Both Outflow Pathways? - Summary - MDSpire

Should Surgeons Target Both Outflow Pathways?

Nathan M. Radcliffe, MD, Editor, Glaucoma Physician, and Sean Ianchulev, MD, MPH, New York Eye and Ear of Mount Sinai, discuss whether addressing both trabecular and uveoscleral pathways could improve outcomes in moderate to advanced disease.

  • April 11, 2026

  • 3 min

Share

Original Source(s)

Should Surgeons Target Both Outflow Pathways?

  • April 11, 2026

Related Content

Improving Glaucoma Clinic Workflow

At ASCRS 2026, Sahar Bedrood, MD, PhD, outlined workflow changes that reduce bottlenecks and improve clinic throughput.

FOXC1 Duplications Linked to Early-Onset Glaucoma

FOXC1 duplications were the second most common monogenic finding among genetically solved juvenile open-angle glaucoma cases in one registry, supporting the use of copy-number variant analysis in early-onset glaucoma testing.

New Generic Expands Glaucoma Options

Amneal Pharmaceuticals launches generic bimatoprost 0.01% in US

  • May 11, 2026

  • 2 min